Reports for APO-DABIGATRAN
Brand name APO-DABIGATRAN |
|---|
Company Name
APOTEX INC
|
Drug Identification Number
02468905 |
Ingredients
DABIGATRAN ETEXILATE |
Ingredient Strength
110 MG |
ATC Code
B01AE |
ATC Descriptor
ANTITHROMBOTIC AGENTS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| APO-DABIGATRAN | 60 BTL | Resolved | 2019-06-26 | 2022-10-07 | 87509 |
| APO-DABIGATRAN | 60 BTL | Resolved | 2022-11-20 | 2023-01-20 | 175318 |
| APO-DABIGATRAN | 60 BLS | Resolved | 2024-02-09 | 2024-02-23 | 219152 |
| APO-DABIGATRAN | 60 BLS | Resolved | 2024-06-14 | 2024-09-20 | 230561 |
| APO-DABIGATRAN | 60 BLS | Actual shortage | 2024-11-15 | 2024-11-15 | 243170 |
| APO-DABIGATRAN | 60 BTL | Resolved | 2024-12-05 | 2025-01-24 | 244888 |
| APO-DABIGATRAN | 60 BTL | Actual shortage | 2025-04-10 | 2025-05-01 | 254858 |
Showing 1 to 7 of 7
Discontinuation reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0